Cuproptosis: the mechanisms of copper-induced cell death and its implication in colorectal cancer
- PMID: 40397118
- DOI: 10.1007/s00210-025-04263-z
Cuproptosis: the mechanisms of copper-induced cell death and its implication in colorectal cancer
Abstract
Colorectal cancer (CRC) represents a prevalent neoplastic disorder of the digestive tract, characterized by elevated incidence and mortality rates. The cellular metabolism of copper within CRC cells is frequently dysregulated, indicating that modifications to copper concentrations may induce cell death and potentially enhance the overall suppression of tumor progression. Cuproptosis, a recently identified form of cellular death, occurs when copper ions bind directly to the lipoylated components of the citric acid cycle (CAC) within mitochondrial respiration, thereby disrupting the balance of iron-sulfur cluster (Fe-S cluster) proteins and ultimately leading to protein toxic stress. The defining traits of cuproptosis include dependence on Cu2+ concentrations and pronounced expression in cells engaged in mitochondrial respiration. This novel mechanism has attracted significant interest within the cancer research community due to its substantial therapeutic potential in oncology. Treatments based on copper demonstrate an inhibitory effect on tumor proliferation and may facilitate approaches for treating tumors that are resistant to conventional chemotherapy. This article aims to review the significance of cuproptosis in CRC, positing that it may serve as a promising strategy for antitumor therapy and an innovative treatment paradigm to address drug resistance in cancer.
Keywords: CRC; Cell death; Colorectal cancer; Copper; Cuproptosis.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval and consent to participate: It is not applicable. Human ethics: It is not applicable. Consent for publication: It is not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
The role of cuproptosis in gastric cancer.Front Immunol. 2024 Oct 30;15:1435651. doi: 10.3389/fimmu.2024.1435651. eCollection 2024. Front Immunol. 2024. PMID: 39539553 Free PMC article. Review.
-
Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy.Front Oncol. 2025 Jan 9;14:1522919. doi: 10.3389/fonc.2024.1522919. eCollection 2024. Front Oncol. 2025. PMID: 39850821 Free PMC article. Review.
-
Cuproptosis and physical training.Clin Hemorheol Microcirc. 2024;88(3):337-350. doi: 10.3233/CH-242329. Clin Hemorheol Microcirc. 2024. PMID: 39031346 Review.
-
Impact of cuproptosis in gliomas pathogenesis with targeting options.Chem Biol Interact. 2025 Feb 25;408:111394. doi: 10.1016/j.cbi.2025.111394. Epub 2025 Jan 21. Chem Biol Interact. 2025. PMID: 39848557 Review.
-
Copper in colorectal cancer: From copper-related mechanisms to clinical cancer therapies.Clin Transl Med. 2024 Jun;14(6):e1724. doi: 10.1002/ctm2.1724. Clin Transl Med. 2024. PMID: 38804588 Free PMC article. Review.
References
-
- Al-Batran S-E, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 393:1948–1957 - PubMed - DOI
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous